Telehealth & Digital Health

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

A French medtech firm is deploying a non-invasive ultrasound device that repairs heart valves, creating a new market for patients too frail for surgery.

With air quality plummeting, a new wellness market is booming. We investigate the science and business behind lung health supplements for wildfire season.

Elevance Health is deploying a suite of AI-driven tools to manage chronic illness. Is this the future of healthcare or just a new set of digital hurdles?

New data reveals upstream patient guidance slashes surgical costs, challenging the old guard of healthcare management and signaling a new era of digital-first care.

A new strategic alliance between a pharma giant and a leading non-profit is deploying a $20M plan to close the deadly prostate cancer survival gap.

As Orca Bio builds a manufacturing empire from Sacramento to Princeton, it's not just preparing for a new drug launch—it's trying to solve the biggest puzzle in biotech.

A 23% national drop in overdose deaths signals progress, but regional disparities and a volatile drug supply show the fight is far from over.

A new partnership between Klick Labs and Mayo Clinic aims to detect disease using your voice. But what does this mean for the future of our health systems?

A new partnership between cliexa and OpiSafe integrates predictive AI with patented workflow tools, promising to reshape opioid stewardship from within the EMR.

A new data-driven framework aims to move senior living beyond bingo attendance, tackling the silent epidemic of loneliness. But can technology truly measure connection?

While CEO Craig Chambliss's EY award makes headlines, the real story is Neurelis's disruption of epilepsy care and its ambitious pipeline for brain disorders.

Legend Biotech's stunning trial results for an 'in vivo' CAR-T therapy could make advanced cancer treatment faster, safer, and accessible to all.

With a landmark therapy for Sanfilippo Syndrome nearing the FDA, Spruce adds veteran marketing and finance chiefs. A look at the talent behind the transition.

An AI named Grace is now collecting hospital bills more effectively and with higher patient satisfaction than humans. Is this the future of service or a step too far?

Elysium Health's new Creatine+ isn't just a supplement; it's a signal of a massive structural shift where human vitality becomes a core economic asset.

Amid new Ebola fears, one biotech's rapid C1 platform promises 15-day biologics, eyeing a $25B market beyond just pandemic response. But can it deliver?

As 250 million people await a drug for lymphatic diseases, Celltaxis appoints a new CEO to drive its promising inflammation-targeting therapy toward the finish line.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

A new digital marketplace lets dentists bid for your business, promising transparency and lower costs. But can this tech disruption solve the dental affordability crisis?